DealsNew Mountain to acquire CRO Emmes from Behrman CapitalBehrman Capital has been Emmes' majority investor since March 2019.ByIris Dorbian21 June 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs